Aadi Bioscience Stock Investor Sentiment

AADI Stock  USD 2.34  0.06  2.63%   
Under 57% of all Aadi Bioscience's traders are looking to take a long position. The analysis of the overall investor sentiment regarding Aadi Bioscience suggests that some traders are interested. Aadi Bioscience's investing sentiment shows overall attitude of investors towards Aadi Bioscience.
  

Aadi Bioscience Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Aadi Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at news.google.com         
Aadi Bioscience Insider Sold Shares Worth 185750, According to a ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Aadi Bioscience to Report Third Quarter 2023 Results and ... - Marketscreener.com
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update
Yahoo News
over a year ago at thelincolnianonline.com         
Aadi Bioscience, Inc. Short Interest Update
news
over a year ago at news.google.com         
Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus ... - PR Newswire
Google News at Macroaxis
over a year ago at hawaiinewsnow.com         
Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Can...
news
over a year ago at finance.yahoo.com         
Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Can...
Yahoo News
over a year ago at thelincolnianonline.com         
Aadi Bioscience, Inc. Short Interest Update
news
over a year ago at news.google.com         
Aadi Bioscience Announces Poster Presentations at 2023 AACR ... - Marketscreener.com
Google News at Macroaxis
over a year ago at hawaiinewsnow.com         
Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Mo...
news
over a year ago at news.google.com         
Aadi Bioscience Corporate Presentation -October 06, 2023 at 04 ... - Marketscreener.com
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society 20...
Yahoo News
over a year ago at hawaiinewsnow.com         
Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society 20...
news
over a year ago at news.google.com         
Executive Chairman of Aadi Bioscience Sold 179K In Stock - Aadi Bioscience - Benzinga
Google News at Macroaxis
over a year ago at benzinga.com         
Executive Chairman of Aadi Bioscience Sold 179K In Stock
benzinga news
Far too much social signal, news, headlines, and media speculation about Aadi Bioscience that are available to investors today. That information is available publicly through Aadi media outlets and privately through word of mouth or via Aadi internal channels. However, regardless of the origin, that massive amount of Aadi data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aadi Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aadi Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aadi Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aadi Bioscience alpha.

Aadi Bioscience Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 9583 shares by Neil Desai of Aadi Bioscience at 7.446 subject to Rule 16b-3
09/05/2024
2
Aadi Bioscience executive chairman sells shares worth over 68,000 - Investing.com
09/06/2024
3
Disposition of 32558 shares by David Lennon of Aadi Bioscience subject to Rule 16b-3
10/02/2024
4
Acquisition by Dalal Anupam of 18573 shares of Aadi Bioscience at 13.46 subject to Rule 16b-3
10/04/2024
5
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update - Morningstar
10/30/2024
6
Aadi Bioscience Inc Q3 2024 Earnings Revenue Hits 7. ...
11/06/2024
7
BML Capital Management LLC Takes 4.12 Million Position in Aadi Bioscience, Inc. - MarketBeat
11/12/2024

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets